Idf diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
This process typically takes 48 hours
Understanding tirzepatide's mechanism is essential when evaluating potential adverse effects, including concerns about pancreatic safety, as the incretin pathway has complex interactions with pancreatic tissue
Initial Assessment Template Every initial GLP-1 visit should generate a single chart note containing: chief complaint, BMI and weight history, comorbidities, medication and supplement review, contraindications screen (including MTC/MEN-2 family history), allergy history, social history (alcohol, tobacco, substance use), prior weight-loss interventions, treatment plan with specific drug and titration schedule, and prescriber signature
Vial Duration Each 3ml vial lasts approximately 610 days depending on your prescribed dose
Clinical Evidence We currently have very limited evidence in support of the use of GLP-1 or dual GIP/GLP-1 medications in treating adults with type 1 diabetes
